CJ
NVO

Caitlin John’s Novo Nordisk NVO Stock Holding History

Caitlin John’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
299
– – 0.01% 551
2026
Q1 		$11K Buy
299
+7
+2% +$332 0.01% 508
2025
Q4 		$14.9K Buy
292
+262
+873% +$13.4K 0.01% 481
2025
Q3 		$1.68K Buy
+30
New +$1.76K ﹤0.01% 707
2025
Q1 		– Sell
-14
Closed -$1.22K – 577
2024
Q4 		$1.22K Hold
14
– – ﹤0.01% 714
2024
Q3 		$1.52K Hold
14
– – ﹤0.01% 689
2024
Q2 		$2.03K Hold
14
– – ﹤0.01% 652
2024
Q1 		$1.83K Sell
14
-176
-93% -$21K ﹤0.01% 689
2023
Q4 		$19.7K Buy
+190
New +$18.8K 0.02% 340

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Caitlin John's NVO Position: Q2 2026 in Review

Caitlin John held its Novo Nordisk (NVO) position steady in Q2 2026 at 299 shares worth $14.3K. The position accounts for 0.01% of the portfolio, ranked #551.

Caitlin John first reported a position in NVO in Q4 2023 and has held it in 9 quarters since. The position peaked at $19.7K in Q4 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Caitlin John held 299 shares of Novo Nordisk worth $14.3K as of Q2 2026.
  • Caitlin John left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Caitlin John's portfolio in Q2 2026, its #551 holding.
  • Caitlin John first reported a position in Novo Nordisk in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Novo Nordisk position peaked at $19.7K in Q4 2023.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.